Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Sarepta Therapeutics shares surge 20% after article suggests drug approval possible
Sarepta Therapeutics shares surge 20% after article suggests drug approval possible
Sarepta Therapeutics shares surge 20% after article suggests drug approval possible
Submitted by
admin
on April 28, 2016 - 9:36am
Source:
Marketwatch
News Tags:
Sarepta Therapeutics
Duchenne Muscular Dystrophy
FDA
advisory panels
eteplirsen
Headline:
Sarepta Therapeutics shares surge 20% after article suggests drug approval possible
Do Not Allow Advertisers to Use My Personal information
